Delayed treatment effects, treatment switching and heterogeneous patient populations: How to design and analyze RCTs in oncology
From MaRDI portal
Publication:108613
DOI10.1002/PST.2062WikidataQ98647497 ScholiaQ98647497MaRDI QIDQ108613
Martin Posch, Robin Ristl, Armin Schüler, Heiko Götte, Nicolás M. Ballarini
Publication date: 23 August 2020
Published in: Pharmaceutical Statistics (Search for Journal in Brave)
Related Items (1)
This page was built for publication: Delayed treatment effects, treatment switching and heterogeneous patient populations: How to design and analyze RCTs in oncology